PA
CDMO

Pineridge Advisors’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Pineridge Advisors’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-50
Closed -$618 – 684
2024
Q4 		$618 Hold
50
– – ﹤0.01% 561
2024
Q3 		$569 Hold
50
– – ﹤0.01% 529
2024
Q2 		$357 Hold
50
– – ﹤0.01% 584
2024
Q1 		$335 Sell
50
-208
-81% -$1.43K ﹤0.01% 566
2023
Q4 		$1.68K Buy
+258
New +$1.66K ﹤0.01% 647

Other funds holding CDMO

TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Pineridge Advisors's CDMO Position: Q1 2025 in Review

Pineridge Advisors sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 50 shares — an estimated $618 sold.

Pineridge Advisors first reported a position in CDMO in Q4 2023 and held it in 5 quarters. The position peaked at $1.68K in Q4 2023. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.

  • Pineridge Advisors reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Pineridge Advisors sold 50 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $618.
  • Pineridge Advisors first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2023 and held it in 5 quarters.
  • Pineridge Advisors's Avid Bioservices, Inc. Common Stock position peaked at $1.68K in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.

Based on Pineridge Advisors's 13F filing for Q1 2025, filed 30 Apr 2025.